Foresite Capital Management Iv, LLC Opti Nose, Inc. Transaction History

Foresite Capital Management Iv, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$3.49 - $9.2 $3.04 Million - $8.01 Million	-870,766 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$6.27 - $11.41 $8.57 Million - $15.6 Million	-1,367,240 Reduced 61.09%	870,766 $8.03 Million
Q3 2019 Nov 13, 2019	SELL	$4.75 - $8.38 $1.35 Million - $2.38 Million	-284,183 Reduced 11.27%	2,238,006 $15.7 Million
Q2 2019 Aug 13, 2019	BUY	$6.4 - $10.94 $606,630 - $1.04 Million	94,786 Added 3.9%	2,522,189 $17.9 Million
Q1 2019 May 14, 2019	BUY	$6.1 - $10.3 $4.39 Million - $7.4 Million	718,858 Added 42.07%	2,427,403 $25 Million
Q4 2018 Feb 13, 2019	BUY	$5.84 - $11.92 $1.46 Million - $2.98 Million	250,000 Added 17.14%	1,708,545 $10.6 Million
Q3 2018 Nov 13, 2018	BUY	$12.43 - $29.76 $6.59 Million - $15.8 Million	530,000 Added 57.08%	1,458,545 $18.1 Million
Q2 2018 Aug 14, 2018	BUY	$18.75 - $28.46 $8.34 Million - $12.7 Million	444,939 Added 92.0%	928,545 $26 Million
Q1 2018 May 15, 2018	BUY	$15.91 - $20.82 $534,671 - $699,676	33,606 Added 7.47%	483,606 $9.68 Million
Q4 2017 Feb 13, 2018	BUY	$15.2 - $20.76 $6.84 Million - $9.34 Million	450,000	450,000 $8.51 Million

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $40M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.